Minaprine improves impairment of working memory induced by scopolamine and cerebral ischemia in rats

T Yamamoto1, S Yatsugi, M Ohno

  • 1Department of Pharmacology, Faculty of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan.

Psychopharmacology
|January 1, 1990
PubMed

Insights

Minaprine, a stimulant drug, improved working memory in rats impaired by scopolamine or cerebral ischemia. However, it did not reverse memory deficits caused by ethylcholine aziridinium ion (AF64A).

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cognitive Science

Background:

  • Working memory impairment is a significant challenge in neurological disorders.
  • Scopolamine, AF64A, and cerebral ischemia are common models to study memory deficits.
  • Minaprine is a drug with potential cognitive-enhancing properties.

Purpose of the Study:

  • To investigate the effects of minaprine on working memory impairment induced by scopolamine, AF64A, and cerebral ischemia in rats.
  • To compare minaprine's efficacy with other cognitive enhancers like idebenone and physostigmine.
  • To explore the potential mechanisms underlying minaprine's effects on memory.

Main Methods:

  • A repeated acquisition procedure in a three-panel runway apparatus was used.
  • Rats received minaprine, idebenone, or physostigmine after induction of memory impairment.
  • Memory performance was assessed by measuring errors in the runway task.

Main Results:

  • Minaprine, idebenone, and physostigmine dose-dependently reduced scopolamine-induced working memory errors.
  • Cerebral ischemia significantly increased errors, an effect attenuated by minaprine and physostigmine.
  • Minaprine failed to improve memory deficits induced by AF64A in the dorsal hippocampus.

Conclusions:

  • Minaprine demonstrates therapeutic potential for memory impairments associated with scopolamine and cerebral ischemia.
  • The drug's effects may be mediated by its stimulant action on central cholinergic systems.
  • Minaprine's efficacy is specific to certain types of memory impairment, not universally effective.